000			02025 a2200577 4500
005			20250515110710.0
264		0	_c20080422
008			200804s 0 0 eng d
022			_a0340-6245
024	7		_a10.1160/TH07-10-0624 _2doi
040			_aNLM _beng _cNLM
100	1		_aNeubauer, Horst
245	0	0	_aHow to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification. _h[electronic resource]
260			_bThrombosis and haemostasis _cFeb 2008
300			_a357-62 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdenosine Diphosphate _xanalogs & derivatives
650	0	4	_aAged
650	0	4	_aAlgorithms
650	0	4	_aAngioplasty, Balloon, Coronary _xadverse effects
650	0	4	_aAspirin _xadministration & dosage
650	0	4	_aBlood Platelets _xdrug effects
650	0	4	_aCardiovascular Diseases _xblood
650	0	4	_aClinical Protocols
650	0	4	_aClopidogrel
650	0	4	_aCoronary Artery Disease _xblood
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Monitoring _xmethods
650	0	4	_aDrug Resistance
650	0	4	_aFeasibility Studies
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPilot Projects
650	0	4	_aPlatelet Aggregation _xdrug effects
650	0	4	_aPlatelet Aggregation Inhibitors _xadministration & dosage
650	0	4	_aPlatelet Function Tests
650	0	4	_aProspective Studies
650	0	4	_aPurinergic P2 Receptor Antagonists
650	0	4	_aReceptors, Purinergic P2 _xblood
650	0	4	_aReceptors, Purinergic P2Y12
650	0	4	_aStents
650	0	4	_aTiclopidine _xadministration & dosage
700	1		_aLask, Sebastian
700	1		_aEngelhardt, Andreas
700	1		_aMügge, Andreas
773	0		_tThrombosis and haemostasis _gvol. 99 _gno. 2 _gp. 357-62
856	4	0	_uhttps://doi.org/10.1160/TH07-10-0624 _zAvailable from publisher's website
999			_c17782831 _d17782831